Biotechnology and Bioengineering · 2021 · 16 citations · 23 references
Life SciencesBiochemistryBiotechnologyProtein EngineeringProtein FoldingProtein TranslationAntibody ConjugationCo-translational Protein FoldingEnzyme ExpressionProtein Expression EngineeringProtein SynthesisTherapeutic Protein EngineeringAmino AcidsBacterial Batch FermentationBacterial Protein ProductionCell-free Antibody SynthesisCell-free Protein FoldingConstitutive PromotersProtein ProductionUnnatural Amino Acid Incorporation
Recent advances in cell-free protein synthesis have enabled the folding and assembly of full-length antibodies at high titers with extracts from prokaryotic cells. Coupled with the facile engineering of the Escherichia coli translation machinery, E. coli based in vitro protein synthesis reactions have emerged as a leading source of IgG molecules with nonnatural amino acids incorporated at specific locations for producing homogeneous antibody-drug conjugates (ADCs). While this has been demonstrated with extract produced in batch fermentation mode, continuous extract fermentation would facilitate supplying material for large-scale manufacturing of protein therapeutics. To accomplish this, the IgG-folding chaperones DsbC and FkpA, and orthogonal tRNA for nonnatural amino acid production were integrated onto the chromosome with high strength constitutive promoters. This enabled co-expression of all three factors at a consistently high level in the extract strain for the duration of a 5-day continuous fermentation. Cell-free protein synthesis reactions with extract produced from cells grown continuously yielded titers of IgG containing nonnatural amino acids above those from extract produced in batch fermentations. In addition, the quality of the synthesized IgGs and the potency of ADC produced with continuously fermented extract were indistinguishable from those produced with the batch extract. These experiments demonstrate that continuous fermentation of E. coli to produce extract for cell-free protein synthesis is feasible and helps unlock the potential for cell-free protein synthesis as a platform for biopharmaceutical production.
23
Expanding the Genetic Code of <i>Escherichia coli</i>
Lei Wang, Ansgar Brock, Brad Herberich et al. · Science · 2001 · 1.5K citations
James Zawada, Gang Yin, Alexander Steiner et al. · Biotechnology and Bioengineering · 2011 · 416 citations · Full text